Skip to main content
. 2022 Jul 28;24(3):598. doi: 10.3892/etm.2022.11536

Figure 1.

Figure 1

Flow diagram of the study showing the inclusion and exclusion of participants with NAFLD and HCs. HCs, healthy controls; NAFLD, non-alcoholic fatty liver disease; NAFLD-cirrhosis, NAFLD-related cirrhosis; NASH, non-alcoholic steatohepatitis.